* STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected
to show
a rise in quarterly revenue when it reports results on November
9.
* The Horsham Pennsylvania-based company is expected to
report a
4.9% increase in revenue to $8.092 million from $7.71 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for STRATA Skin
Sciences Inc
is for a loss of 6 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for STRATA Skin
Sciences Inc is $4, above its last closing price of $0.89.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.06 -0.05 -0.05 Met 0
Mar. 31 2022 -0.06 -0.06 -0.07 Missed -16.7
Dec. 31 2021 -0.02 -0.02 -0.02 Met 20
Sep. 30 2021 -0.05 -0.05 -0.02 Beat 60
Jun. -0.05 -0.04 0.03 Beat 166.7
30 2021
Mar. 31 2021 -0.04 -0.04 -0.07 Missed -75
Dec. 31 2020 -0.04 -0.03 -0.01 Beat 62.5
Sep. 30 2020 -0.05 -0.04 -0.04 Met -9.1
This summary was machine generated November 8 at 03:08 GMT. All
figures in US dollars unless otherwise stated